CervoMed annual free cash flow
2014
2015
2016
2017
CervoMed reported −$12.8M in free cash flow for fiscal 2017, a decrease of $2.0M from the previous fiscal year.
View full CervoMed company overview| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2017 | 2017-12-31 | −$12.8M | −$2.0M | — | — |
| 2016 | 2016-12-31 | −$10.8M | −$5.5M | — | — |
| 2015 | 2015-12-31 | −$5.2M | $3.9M | — | — |
| 2014 | 2014-12-31 | −$9.1M | — | — | — |
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2017 | 2017-12-31 | −$2.3M | −$877,342 | — | — |
| Q3 2017 | 2017-09-30 | −$4.3M | −$2.4M | — | — |
| Q2 2017 | 2017-06-30 | −$2.8M | $55,819 | — | — |
| Q1 2017 | 2017-03-31 | −$3.4M | $1.2M | — | — |
| Q4 2016 | 2016-12-31 | −$1.4M | $878,451 | — | — |
| Q3 2016 | 2016-09-30 | −$1.9M | −$880,325 | — | — |
| Q2 2016 | 2016-06-30 | −$2.9M | −$1.9M | — | — |
| Q1 2016 | 2016-03-31 | −$4.6M | −$3.7M | — | — |
| Q4 2015 | 2015-12-31 | −$2.3M | — | — | — |
| Q3 2015 | 2015-09-30 | −$984,436 | — | — | — |
| Q2 2015 | 2015-06-30 | −$1.0M | — | — | — |
| Q1 2015 | 2015-03-31 | −$940,961 | — | — | — |
CervoMed's latest reported quarter, Q4 2017, generated −$2.3M in free cash flow, a decrease of $877,342 year over year.
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review CervoMed filings at SEC.gov ↗